(Q39710843)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

title

Radiation dosimetry of (68)Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

Henrik Hetzheim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Wolfgang Kübler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Clemens Kratochwil

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Frederik L Giesel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Thomas A Hope

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Matthias Eder

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Michael Eisenhut

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Klaus Kopka

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Uwe Haberkorn

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

publication date

3 June 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

number of pages

10

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

1611-1620

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3419-0

Fluorocholine PET/CT in patients with prostate cancer: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3419-0

The value of 18F-choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3419-0

Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3419-0

Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3419-0

A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3419-0

Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3419-0

⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3419-0

Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3419-0

A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3419-0

68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3419-0

[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3419-0

PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3419-0

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3419-0

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3419-0

Computed tomography-based attenuation correction in neurological positron emission tomography: evaluation of the effect of the X-ray tube voltage on quantitative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3419-0

Radiation dosimetry and first therapy results with a (124)I/ (131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3419-0

Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis

21 January 2018

1 reference

12 December 2020

Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy

1 reference

12 December 2020

Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissectio

1 reference

12 December 2020

The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions.

1 reference

12 December 2020

Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer

1 reference

12 December 2020

OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine

1 reference

12 December 2020

99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer

1 reference

12 December 2020

Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases

1 reference

12 December 2020

Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy

1 reference

12 December 2020

Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer

1 reference

12 December 2020

First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer

1 reference

12 December 2020

[(68)Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice

1 reference

12 December 2020

10.1007/S00259-016-3419-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27260521%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference